Poly(ADP-ribose) polymerase-1 activity facilitates the dissociation of nuclear proteins from platinum-modified DNA

Bioorganic and Medicinal Chemistry

Volumn 16, Issue 23, 2008, Pages 10121-10128

  Guggenheim, Evan R ^a   Ondrus, Alison E ^a   Movassaghi, Mohammad ^a   Lippard, Stephen J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Anticancer drugs; Bone cancer; Cervical cancer; Cisplatin; Molecular mechanism; Pancreatic cancer; Photo cross linking; Poly(ADP ribosyl)ation; Testicular cancer

Indexed keywords

4 AMINO 1,8 NAPHTHALIMIDE; ABT 888; ANTINEOPLASTIC AGENT; CEP 6800; CISPLATIN; NAPHTHALIMIDE DERIVATIVE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NUCLEAR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL ASSAY; CELL KILLING; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DISSOCIATION; DNA DAMAGE; DNA MODIFICATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HELA CELL; HUMAN; HUMAN CELL; OSTEOSARCOMA; OSTEOSARCOMA CELL; PANCREAS CANCER; PROTEIN DNA BINDING; SENSITIZATION; TESTIS CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; CELL EXTRACTS; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; ENZYME INHIBITORS; HELA CELLS; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; NUCLEAR PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; TUMOR CELLS, CULTURED;

EID: 55749095538     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.09.074     Document Type: Article

References (38)

1. Jamieson E.R., and Lippard S.J. Chem. Rev. 99 (1999) 2467
2. Feazell R.P., Nakayama-Ratchford N., Dai H., and Lippard S.J. J. Am. Chem. Soc. 129 (2007) 8438
3. Wang D., and Lippard S.J. Nat. Rev. Drug Discov. 4 (2005) 307
4. Jung Y., and Lippard S.J. Chem. Rev. 107 (2007) 1387
5. Guggenheim, E. R.; Xu, D.; Zhang, C. X.; Chang, P. V.; Lippard, S. J. ChemBioChem 2008, in press
6. Zhang C.X., Chang P.V., and Lippard S.J. J. Am. Chem. Soc. 126 (2004) 6536
7. Schreiber V., Dantzer F., Amé J.-C., and de Murcia G. Nat. Rev. Mol. Cell Biol. 7 (2006) 517
8. Nguewa P.A., Fuertes M.A., Alonso C., and Perez J.M. Mol. Pharmacol. 64 (2003) 1007
9. Bouchard V.J., Rouleau M., and Poirier G.G. Exp. Hematol. 31 (2003) 446
10. Audebert M., Salles B., and Calsou P. J. Biol. Chem. 279 (2004) 55117
11. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., and Iliakis G. Nucleic Acids Res. 34 (2006) 6170
12. Yu S.-W., Andrabi S.A., Wang H., Kim N.S., Poirier G.G., Dawson T.M., and Dawson V.L. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 18314
13. Zhang W., Zhang C., Narayani N., Du C., and Balaji K.C. Cancer Lett. 255 (2007) 127
14. Amaravadi R.K., and Thompson C.B. Clin. Cancer Res. 13 (2007) 7271
15. Kim M.Y., Zhang T., and Kraus W.L. Genes Dev. 19 (2005) 1951
16. Fahrer J., Kranaster R., Altmeyer M., Marx A., and Bürkle A. Nucleic Acids Res. 35 (2007) e143
17. Pleschke J.M., Kleczkowska H.E., Strohm M., and Althaus F.R. J. Biol. Chem. 275 (2000) 40974
18. Ditsworth D., Zong W.-X., and Thompson C.B. J. Biol. Chem. 282 (2007) 17845
19. Tanuma S., and Johnson G.S. J. Biol. Chem. 258 (1983) 4067
20. Keil C., Gröbe T., and Oei S.L. J. Biol. Chem. 281 (2006) 34394
21. Horton J.K., Stefanick D.F., Naron J.M., Kedar P.S., and Wilson S.H. J. Biol. Chem. 280 (2005) 15773
22. Zong W.-X., Ditsworth D., Bauer D.E., Wang Z.-Q., and Thompson C.B. Genes Dev. 18 (2004) 1272
23. Bürkle A., Chen G., Küpper J.H., Grube K., and Zeller W.J. Carcinogenesis 14 (1993) 559
24. Shino Y., Itoh Y., Kubota T., Yano T., Sendo T., and Oishi R. Free Radical Biol. Med. 35 (2003) 966
25. Gambi N., Tramontano F., and Quesada P. Biochem. Pharmacol. 75 (2008) 2356
26. Miknyoczki S.J., Jones-Bolin S., Pritchard S., Hunter K., Zhao H., Wan W., Ator M., Bihovsky R., Hudkins R., Chatterjee S., Klein-Szanto A., Dionne C., and Ruggeri B. Mol. Cancer. Ther. 2 (2003) 371
27. Donawho C.K., Luo Y., Luo Y., Penning T.D., Bauch J.L., Bouska J.J., Bontcheva-Diaz V.D., Cox B.F., DeWeese T.L., Dillehay L.E., Ferguson D.C., Ghoreishi-Haack N.S., Grimm D.R., Guan R., Han E.K., Holley-Shanks R.R., Hristov B., Idler K.B., Jarvis K., Johnson E.F., Kleinberg L.R., Klinghofer V., Lasko L.M., Liu X., Marsh K.C., McGonigal T.P., Meulbroek J.A., Olson A.M., Palma J.P., Rodriguez L.E., Shi Y., Stavropoulos J.A., Tsurutani A.C., Zhu G.-D., Rosenberg S.H., Giranda V.L., and Frost D.J. Clin. Cancer Res. 13 (2007) 2728
28. Helleday T., Petermann E., Lundin C., Hodgson B., and Sharma R.A. Nat. Rev. Cancer 8 (2008) 193
29. Chatterjee, S.; Diebold, J. L.; Dunn, D.; Hudkins, R. L.; Dandu, R.; Wells, G. J.; Zulli, A. L.; (Cephalon Inc.) U.S. Patent Appl. No. 11/455,356, 2006.
30. Hudkins R.L., and Park C.H. J. Heterocycl. Chem. 40 (2003) 135
31. Tao M., Park C.H., Bihovsky R., Wells G.J., Husten J., Ator M.A., and Hudkins R.L. Bioorg. Med. Chem. Lett. 16 (2006) 938
32. Katritzky A.R., and Akutagawa K. Tettahedron Lett. 26 (1985) 5935
33. Shiokawa M., Masutani M., Fujihara H., Ueki K., Nishikawa R., Sugimura T., Kubo H., and Nakagama H. Jpn. J. Clin. Oncol. 35 (2005) 97
34. De Soto J.A., and Deng C.-X. Int. J. Med. Sci. 3 (2006) 117
35. Bernges F., and Zeller W.J. J. Cancer Res. Clin. Oncol. 122 (1996) 665
36. Still W.C., Kahn M., and Mitra A. J. Org. Chem. 43 (1978) 2923
37. Pangborn A.B., Giardello M.A., Grubbs R.H., Rosen R.K., and Timmers F.J. Organometallics 15 (1996) 1518
38. Fatiadi A.J. Synthesis 2 (1976) 65